Detalhe da pesquisa
1.
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases.
J Chemother
; 35(6): 576-582, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36537289
2.
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations.
Genes (Basel)
; 12(5)2021 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33946594